Abstract
Inflammatory bowel disorders (IBD) are a significant cause of disease burden globally. Interleukin 23 (IL 23) is one of many important cytokines that can be studied in this context. The Interleukin- 23 is a critical aspect of the performing of irritation and is intently tied to it. So there are still many unanswered questions about the function every one of them performs in this orchestra in phrases of their pro- and anti-inflammatory elements. In this study, one hundred age- and sex-matched IBD patients had been included in this study. Measurement of serum IL-23 is done by the use of an ELISA kit. Serum IL-23 used to be appreciably extended in IBD sufferers compared with healthy controls (P<0.001). This study indicates that serum IL-23 is higher in IBD patients compared to healthful controls.
First Page
157
Last Page
165
Recommended Citation
Hayyawi, Qabas Salman; Treaf, Mohammed Filyyh; and Falih, Ekhlas Saddam
(2023)
"Estimation of IL-23 in ulcerative colitis and Crohn’s disease in sample of Iraqi patients with inflammatory bowel disease,"
Al-Nisour Journal for Medical Sciences: Vol. 5:
Iss.
1, Article 14.
DOI: https://doi.org/10.70492/2664-0554.1102